Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, T-Cell 5Recurrence 2Lymphoma, T-Cell, Peripheral 2Lymphoma 2Immunoblastic Lymphadenopathy 2Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Large Granular Lymphocytic 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

fludarabine phosphate 2fludarabine 2Cyclophosphamide 2thymoglobulin 1ruxolitinib 1duvelisib 1blinatumomab 1Whole-Body Irradiation 1Transplantation 1Thiotepa 1Tacrolimus 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Mesna 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Large Granular Lymphocytic × duvelisib × 90 days × Clear all
NCT05010005 2026-04-09

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
70 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡